세포고사의 핵의학영상

In Vivo Nuclear Imaging of Apoptosis

  • 이태섭 (원자력의학원 싸이클로트론응용연구실) ;
  • 천기정 (원자력의학원 핵의학과)
  • Lee, Tae-Sup (Laboratory of Cyclotron Application, Korea Institute of Radiological and Medical Sciences) ;
  • Cheon, Gi-Jeong (Department of Nuclear Medicine, Korea Institute of Radiological and Medical Sciences)
  • 발행 : 2004.04.30

초록

Apoptosis plays a role in the pathophysiology of many kinds of diseases and in the response of treatment. Compared to the necrosis, the apoptosis is a genetically controlled and energy-dependent process which removes the unwanted cells from the body; programmed cell death or cell suicide. During the apoptosis, phosphatidylserine is expressed in the cytoplasmic outer membrane in the early phase. Annexin V, an endogenous human protein (MW=35 kD), has an affinity of about $10^{-9}\;M$ for the phosphatidylserine exposed on the outer membrane of apoptotic cells. Annexin V can be radiolabeled with $^{99m}Tc$ by HYNIC or EC chelators, which can be used as an radiotracer for the in vivo imaging of apoptosis. In this article, we reviewed the apoptosis, radiolabeling of annexin V, and the experimental and clinical data using annexin V imaging.

키워드

참고문헌

  1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57. https://doi.org/10.1038/bjc.1972.33
  2. Sarraf CE, Bowen ID. Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell Tissue Kinet 1988;21:45-9.
  3. Wyllie AH. Apoptosis. Br J Cancer 1993;67:205-8. https://doi.org/10.1038/bjc.1993.40
  4. Allen RT, Hunter WJ 3rd, Agrawal DK. Morphological and biochemical characterization and analysis of apoptosis. J Pharmacol Toxicol Methods 1997;37:215-28. https://doi.org/10.1016/S1056-8719(97)00033-6
  5. Naito M, Nagashima K, Mashima T, Tsuruo T. Phosphatidylserine externalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. Blood 1997;89:2060-6.
  6. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12. https://doi.org/10.1126/science.281.5381.1309
  7. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997;89:1121-32.
  8. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281(5381):1312-6. https://doi.org/10.1126/science.281.5381.1312
  9. Evan G, Littlewood T. A matter of life and cell death. Science 1998;281:1317-22. https://doi.org/10.1126/science.281.5381.1317
  10. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle-cellerythrocytes by means of annexin V binding. J Lab Clin Med 1994;123:741-8.
  11. Tait JF, Brown DS, Gibson DF, Blankenberg FG, Strauss HW. Development and characterization of annexin V mutants with endogenous chelation sites for 99mTc. Bioconjug Chem 2000;11:918-25. https://doi.org/10.1021/bc000059v
  12. Collingridge DR, Glaser M, Osman S, Barthel H, Hutchinson OC, Luthra SK, Brady F, Bouchier-Hayes L, Martin SJ, Workman P, Price P, Aboagye EO. In vitro selectivity, in vivo biodistribution and tumour uptake of annexin V radiolabelled with a positron emitting radioisotope. Br J Cancer 2003;89:1327-33. https://doi.org/10.1038/sj.bjc.6601262
  13. Stratton JR, Dewhurst TA, Kasina S, Reno JM, Cerqueira MD, Baskin DG, Tait JF. Selective uptake of radiolabeled annexin V on acute porcine left atrial thrombi. Circulation 1995;92:3113-21. https://doi.org/10.1161/01.CIR.92.10.3113
  14. Yang DJ, Azhdarinia A, Wu P, Yu DF, Tansey W, Kalimi SK, Kim EE, Podoloff DA. In vivo and in vitro measurement of apoptosis in breast cancer cells using 99mTc-EC-annexin V. Cancer Biother Radiopharm 2001;16:73-83. https://doi.org/10.1089/108497801750096087
  15. Larsen SK, Solomon HF, Caldwell G, Abrams MJ. '99mTc'tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. Bioconjug Chem 1995;6:635-8. https://doi.org/10.1021/bc00035a020
  16. Blankenberg FG, Katsikis PD, Tait JF In vivo detection and of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349-53.
  17. Kemerink GJ, Boersma HH, Thimister PW, Hofstra L, Liem IH, Pakbiers MT, Janssen D, Reutelingsperger CP, Heidendal GA. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans. Eur J Nucl Med 2001;28:1373-8. https://doi.org/10.1007/s002590100578
  18. Ke S, Wen X, Wu QP, Wallac S, Charnsangavej C, Stachowiak AM, Stephan CL, Abbruzzese JL, Podoloff DA, Li C. Imaging taxene-induced tumor apoptosis using pegylated, 111In-labeled annexin V. J Nucl Med 2004;45:108-115.
  19. Zijlstra S, Gunawan J, Burchert W. Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl Radiat Isot 2003;58:201-7. https://doi.org/10.1016/S0969-8043(02)00302-0
  20. Murakami Y, Takamatsu H, Taki J, Tatsumi M, Noda A, Ichise R, Tait JF, Nishimura S. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur J Nucl Med Mol Imaging 2004;31:469-74. https://doi.org/10.1007/s00259-003-1378-8
  21. Locke S, Brauer M. Response of the rat liver in situ to bromobenzene-in vivo proton MRI and 31P MRS studies. Toxicol Appl Pharmacol 1991;110:416-428. https://doi.org/10.1016/0041-008X(91)90043-E
  22. Hakumaki JM, Poptani H, Puumalainen AM, Loimas S, Paljarvi LA, Yla-Herttuala S et al. Quantitative 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998;58:3791-9.
  23. D'Arceuil HE, de Crespigny AJ, Rother J, Seri S, Moseley ME, Stevenson DK, et al. Diffusion and perfusion magnetic resonance imaging of the evolution of hypoxic ischemic encephalopathy in the neonatal rabbit. J Magn Reson Imaging 1998;8:820-8. https://doi.org/10.1002/jmri.1880080411
  24. Zhao M, Pipe J, Bonnett J, Evelhoch J. Early detection of treatment response by diffusion-weighted 1H NMR spectroscopy in a murine tumour in vivo. Br. J. Cancer 1996;73:61–64.
  25. Brauer M. In vivo monitoring of apoptosis. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:323-31. https://doi.org/10.1016/S0278-5846(03)00026-5
  26. Blankenberg FG, Tait JF, Strauss HW. Apoptotic cell death: is implications for imaging in the next millennium. Eur J Nucl Med 2000;27:359-67. https://doi.org/10.1007/s002590050046
  27. Blankenberg FG, Storrs RW, Naumovski L, Goralski T, Spielman D. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 1996;87:1951-6.
  28. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, et al. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997;89:3778-86.
  29. Remy C, Fouilhe N, Barba I, Sam-Lai E, Lahrech H, Cucurella MG, et al. Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets. Cancer Res 1997;57:407-14.
  30. Veale MF, Roberts NJ, King GF, King NJ. The generation of 1H-NMR-detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. Biochem Biophys Res Commun 1997;239:868-74. https://doi.org/10.1006/bbrc.1997.7566
  31. Brauer M, Yau M, Foley L, Baggley A. Bioenergetic and metabolic changes induced in mouse liver in vivo during anti-Fas induced apoptosis. Proc Can Fed Biol Soc 2002;45:F098.
  32. Zhao M, Beauregard D, Loizou L, Davletov B, Bindle K. Noninvasive detection of apoptosis using MRI and a targeted contrast agent. Nat Med 2001;7:1241-1244. https://doi.org/10.1038/nm1101-1241
  33. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998;95:6349-54. https://doi.org/10.1073/pnas.95.11.6349
  34. Blankenberg FG, Strauss HW. Non-invasive diagnosis of acute heart- or lung-transplant rejection using radiolabeled annexin V. Pediatr Radiol 1999;29:299-305. https://doi.org/10.1007/s002470050593
  35. Blankenberg FG, Tait, J, Ohtsuki K, StraussHW. Apoptosis: the importance of nuclear medicine. Nucl Med Commun 2000;21:241-250. https://doi.org/10.1097/00006231-200003000-00008
  36. Blankenberg FG, Strauss HW. Will imaging of apoptosis play a role in clinical care? A tale of mice and men. Apoptosis. 2001;6:117-23.
  37. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997;3:1457-1466.
  38. Belhocine T, Steinmetz N, Green A, Rigo P. In vivo imaging of chemotherapy-induced apoptosis in human cancers. Ann NY Acad Sci 2003;1010:525-529. https://doi.org/10.1196/annals.1299.097